Today: 9 June 2026
AT&T stock today: T ends 2025 a touch higher as New Year’s Day shuts U.S. markets
1 January 2026
1 min read

AT&T stock today: T ends 2025 a touch higher as New Year’s Day shuts U.S. markets

NEW YORK, January 1, 2026, 04:26 ET — Market closed

  • AT&T shares rose 0.2% to $24.84 in the last U.S. trading session of 2025.
  • Markets are closed Thursday for New Year’s Day, putting focus on January catalysts.
  • Investors are looking to AT&T’s Jan. 28 results and its Feb. 2 dividend payment.

Shares of AT&T Inc ended the final U.S. session of 2025 up 0.2% at $24.84 on Wednesday, as traders wrapped up year-end positioning ahead of the New Year’s Day holiday closure.

The holiday break matters now because it concentrates attention on the next set of scheduled catalysts rather than day-to-day headlines, with the telecom sector typically drawing buyers when investors lean defensive.

AT&T also tends to trade like a yield play because of its dividend, while its large network buildout keeps investors focused on cash generation and how hard competition forces the company to spend to keep customers.

The stock traded between $24.77 and $24.97 on Wednesday, again coming up just short of the $25 mark that traders have watched as a near-term ceiling.

Telecom peers finished mixed: Verizon Communications Inc edged up 0.1%, while T-Mobile US Inc slipped 0.4%.

The broader tape was weaker into the close, with the S&P 500 ending down 0.74% and the Nasdaq off 0.76% in thin holiday-week trade. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters

With no single AT&T-specific headline dominating late Wednesday, investors have focused on what the next quarterly report needs to show on subscriber momentum and cash. Analysts expect earnings of about 47 cents per share — profit per share — on revenue of $32.85 billion, according to Benzinga.

AT&T said it will release fourth-quarter 2025 results before the New York Stock Exchange opens on Jan. 28 and host a conference call at 8:30 a.m. ET.

The company’s board declared a quarterly common-stock dividend of $0.2775 a share, payable Feb. 2 to shareholders of record as of Jan. 12 — the date a company uses to determine who is eligible to receive the payout.

Before trading resumes on Friday, investors will be watching whether AT&T can hold above the $24 area and make another push toward $25 after Wednesday’s intraday bounce off the session low. U.S. equity markets return to normal hours on Jan. 2 after the holiday closure.

Bond markets, which help set the borrowing-cost backdrop that dividend-heavy stocks are often judged against, were set for an early close on Wednesday and are shut Thursday for New Year’s Day, according to SIFMA.

January’s early macro calendar includes the monthly U.S. jobs report on Jan. 9 and December consumer inflation data on Jan. 13, while the Federal Reserve’s next policy meeting is scheduled for Jan. 27-28.

Stock Market Today

  • Aecon Group TSX Dividend Stock Drops 20% – A Buy for Long-Term Investors
    June 8, 2026, 9:40 PM EDT. Aecon Group (TSX:ARE), a $3.1 billion market cap infrastructure firm, has dropped 20% from its 52-week high, presenting a rare buying opportunity. The company has shifted focus from cyclical civil construction to power projects, including nuclear and utilities, sectors with sustained demand. Aecon completed the Darlington Nuclear Refurbishment under budget and ahead of schedule, highlighting its strong execution. In 2025, revenue hit a record $5.4 billion, with a backlog reaching $10.9 billion in Q1 2026. The company improved margins by moving to collaborative contract models and strengthened its balance sheet by reducing debt. Aecon offers a 1.6% dividend yield with consistent growth, supported by projected free cash flow increases from $35 million in 2025 to $155 million in 2027.

Latest articles

Chip Rally Breaks as Nasdaq Faces Tight Labor Market

Nasdaq rises after hours as chips recover

9 June 2026
Nasdaq jumped 0.86% as chip stocks rebounded, with Intel soaring 11.2% on news Google ordered over 3 million AI chips for 2028, while Apple slid 1.9% after unveiling new AI features. Investors await Wednesday’s May CPI inflation report, which could spark volatility in tech and growth stocks.
Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

Broadcom Stock Rebounds, AI Remains an Open Question for Wall Street

9 June 2026
Broadcom shares jumped 2.8% to $396.60 as chip stocks rebounded after last week’s $1 trillion sector wipeout, but investors remain cautious after Broadcom’s Q2 revenue missed expectations and the company declined to raise its 2027 AI revenue forecast, fueling concerns that rapid AI growth may not meet Wall Street’s high demands.
BitMine Stock Gains as Ether Holdings Approach 5% Target

BitMine Stock Gains as Ether Holdings Approach 5% Target

9 June 2026
BitMine Immersion Technologies shares jumped 6% after revealing ether holdings climbed to 5.54 million tokens, now 4.59% of Ethereum’s supply, with $9.6 billion in crypto, cash and stakes. The company priced a $273.8 million preferred stock offering, with proceeds possibly funding more ETH purchases and staking. BitMine projects $230 million in annualized staking revenues but warns of risks if ETH or financing falters.
Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

Mingteng Stock Jumps 81% After Halting $100M Share Sale Plan

9 June 2026
Mingteng International shares soared 81.3% to $1.94 after the company ended its at-the-market stock sale plan, having raised about $20.6 million in gross proceeds; trading volume hit 24.2 million, dwarfing its $12 million market value, as the move outpaced gains in other U.S.-listed China auto stocks.
Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading
Previous Story

Why FICO Stock Is Sliding Today: Fair Isaac Drops in Thin Year-End Trading

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Next Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Go toTop